105496 (105496)    LAB LOINC (95.3)

Name Value
CODE 105496
COMPONENT A STUDY OF CHEMOTHERAPY DECREASED THE RISK OF DYING FROM COLON CANCER BY ABOUT 30%. AND WAS 95% SURE THAT THE EXPECTED RANGE OF BENEFIT WAS BETWEEN 10% AND 50%
CHECK DIGIT 4
PROPERTY Finding
DATE LAST CHANGED 2024-08-06 00:00:00
CHANGE TYPE ADD
TIME ASPECT POINT
SYSTEM ~PATIENT
SCALE TYPE Ordinal
CLASS PHENX
FULLY SPECIFIED NAME A STUDY OF CHEMOTHERAPY DECREASED THE RISK OF DYING FROM COLON CANCER BY ABOUT 30%. AND WAS 95% SURE THAT THE EXPECTED RANGE OF BENEFIT WAS BETWEEN 10% AND 50%:FIND:PT:~PATIENT:ORD:
SHORTNAME NOT IN THE EXPECTED RANGE OF BENEFIT
LONG COMMON NAME A STUDY OF CHEMOTHERAPY DECREASED THE RISK OF DYING FROM COLON CANCER BY ABOUT 30%. AND WAS 95% SURE THAT THE EXPECTED RANGE OF BENEFIT WAS BETWEEN 10% AND 50%
MASTER ENTRY FOR VUID YES
VUID 5375864
EFFECTIVE DATE/TIME
  • 2024-11-15 00:00:00
    STATUS:   ACTIVE